SCHEMBL19670980

SCHEMBL19670980

CC(C)c1ccc(C(=O)N2CCC(=O)CC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.73
KMT2A Q03164 3/20 0.73
MEN1 O00255 2/20 0.73
LMNA P02545 2/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
POLB P06746 3/20 0.60
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 2/20 0.50
HPGD P15428 3/20 0.48
MGLL Q99685 3/20 0.48
FAAH O00519 1/20 0.47
CHRNA7 P36544 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10495198 0.89 ALDH1A1 (0.89) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL24120195 0.87 HPGD (0.61) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL17465268 0.87 ALDH1A1 (0.69) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL1104737 0.86 ALDH1A1 (0.90) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL10169258 0.86 ALDH1A1 (0.96) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL10169253 0.84 ALDH1A1 (0.87) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL104400 0.83 KMT2A (0.78) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL12089434 0.83 ALDH1A1 (0.78) ALDH1A1KMT2AMEN1LMNASMN1; SMN2
SCHEMBL1799068 0.82 ALDH1A1 (0.64) ALDH1A1KMT2ALMNAPOLBMAPT
SCHEMBL8314360 0.82 CA12 (0.58) ALDH1A1KMT2AMEN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9834521-B2 Choline kinase inhibitors ARIAD PHARMACEUTICALS, INC. (US) 2017-12-05 US disclosed